Skip to main content

Unique Immunological Features of Vascularized Composite Allografts

  • Chapter
  • First Online:
The Science of Reconstructive Transplantation

Part of the book series: Stem Cell Biology and Regenerative Medicine ((STEMCELL))

  • 681 Accesses

Abstract

Vascularized composite allotransplantation (VCA) has emerged as a viable clinical procedure in the past decade. The immunology of VCA remains to be fully investigated and holds much promise to impact the larger field of solid organ transplantation. The initial data suggest that the rate of acute cellular rejection following VCA is higher than seen in solid organs. Yet, the majority of these events are amenable to early diagnosis and completely reversible with timely intervention. Surprisingly, the incidence of chronic rejection in VCA appears to be lower than seen in solid organs. This and other aspects including the role of humoral immunity, ischemia-reperfusion injury, and the significance of donor hematopoietic tissue in VCA grafts will need further study to improve our understanding of VCA. This chapter briefly discusses our current understanding of immunological aspects of VCA.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Dubernard JM, Owen E, Herzberg G, et al. Human hand allograft: report on first 6 months. Lancet. 1999;353:1315–20.

    Article  CAS  PubMed  Google Scholar 

  2. Murray JE. The first successful organ transplants in man. J Am Coll Surg. 2005;200:5–9.

    Article  PubMed  Google Scholar 

  3. Gibson T, Medawar PB. The fate of skin homografts in man. J Anat. 1943;77:299–310 4.

    PubMed  Google Scholar 

  4. Moseley RV, Sheil AG, Mitchell RM, Murray JE. Immunologic relationships between skin and kidney homografts in dogs on immunosuppressive therapy. Transplantation. 1966;4:678–87.

    Article  CAS  PubMed  Google Scholar 

  5. Murray JE. Organ transplantation (skin, kidney, heart) and the plastic surgeon. Plast Reconstr Surg. 1971;47:425–31.

    Article  CAS  PubMed  Google Scholar 

  6. Guild WR, Harrison JH, Merrill JP, Murray J. Successful homotransplantation of the kidney in an identical twin. Trans Am Clin Climatol Assoc. 1955;67:167–73.

    PubMed  Google Scholar 

  7. Brent L, Medawar PB. Tissue transplantation: a new approach to the “typing” problem. Br Med J.1963;2:269–72.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Lee WP, Yaremchuk MJ, Pan YC, Randolph MA, Tan CM, Weiland AJ. Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg. 1991;87:401–11.

    Article  CAS  PubMed  Google Scholar 

  9. Black KS, Hewitt CW, Fraser LA, et al. Composite tissue (limb) allografts in rats. II. Indefinite survival using low-dose cyclosporine. Transplantation. 1985;39:365–8.

    Article  CAS  PubMed  Google Scholar 

  10. Benichou G, Yamada Y, Yun SH, Lin C, Fray M, Tocco G. Immune recognition and rejection of allogeneic skin grafts. Immunotherapy. 2011;3:757–70.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Hautz T, Wolfram D, Grahammer J, et al. Mechanisms and mediators of inflammation: potential models for skin rejection and targeted therapy in vascularized composite allotransplantation. Clin Dev Immunol. 2012;2012:757310.

    Article  PubMed Central  PubMed  Google Scholar 

  12. von Andrian UH, Mackay CR. T-cell function and migration. Two sides of the same coin. New Eng J Med. 2000;343:1020–34.

    Article  CAS  PubMed  Google Scholar 

  13. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol. 2003;284:G15–26.

    Article  CAS  PubMed  Google Scholar 

  14. Fondevila C, Busuttil RW, Kupiec-Weglinski JW. Hepatic ischemia/reperfusion injury–a fresh look. Exp Mol Pathol. 2003;74:86–93.

    Article  CAS  PubMed  Google Scholar 

  15. Dulkanchainun TS, Goss JA, Imagawa DK, et al. Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1. Ann Surg. 1998;227:832–40.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Busuttil RW, Lipshutz GS, Kupiec-Weglinski JW, et al. rPSGL-Ig for improvement of early liver allograft function: a double-blind, placebo-controlled, single-center phase II study. Am J Transplant. 2011;11:786–97.

    Article  CAS  PubMed  Google Scholar 

  17. Hautz T, Zelger B, Grahammer J, et al. Molecular markers and targeted therapy of skin rejection in composite tissue allotransplantation. Am J Transplant. 2010;10:1200–9.

    Article  CAS  PubMed  Google Scholar 

  18. Bejarano PA, Levi D, Nassiri M, et al. The Pathology of full-thickness cadaver skin transplant for large abdominal defects: a proposed grading system for skin allograft acute rejection. Am J Surg Pathol. 2004;28:670–5.

    Article  PubMed  Google Scholar 

  19. Kanitakis J, Petruzzo P, Jullien D, et al. Pathological score for the evaluation of allograft rejection in human hand (composite tissue) allotransplantation. Eur J Dermatol. 2005;15:235–8.

    PubMed  Google Scholar 

  20. Cendales LC, Kirk AD, Moresi JM, Ruiz P, Kleiner DE. Composite tissue allotransplantation: classification of clinical acute skin rejection. Transplantation. 2006;81:418–22.

    Article  PubMed  Google Scholar 

  21. Cendales LC, Kanitakis J, Schneeberger S, et al. The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant. 2008;8:1396–400.

    Article  CAS  PubMed  Google Scholar 

  22. Schneeberger S, Gorantla VS, van Riet RP, et al. Atypical acute rejection after hand transplantation. Am J Transplant. 2008;8:688–96.

    Article  CAS  PubMed  Google Scholar 

  23. Cendales LC, Kirk AD, Moresi JM, Ruiz P, Kleiner DE. Composite tissue allotransplantation: classification of clinical acute skin rejection. Transplantation. 2005;80:1676–80.

    Article  PubMed  Google Scholar 

  24. Hautz T, Brandacher G, Zelger B, et al. Indoleamine 2,3-dioxygenase and foxp3 expression in skin rejection of human hand allografts. Transplant Proc. 2009;41:509–12.

    Article  CAS  PubMed  Google Scholar 

  25. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med.1969;280:735–9.

    Article  CAS  PubMed  Google Scholar 

  26. Patel R, Glassock R, Terasaki PI. Serotyping for homotransplantation. XIX. Experience with an interhospital scheme of cadaver-kidney sharing and tissue typing. JAMA. 1969;207:1319–24.

    Article  CAS  PubMed  Google Scholar 

  27. Gebel HM, Liwski RS, Bray RA. Technical aspects of HLA antibody testing. Curr Opin Organ Transplant. 2013;18:455–62.

    CAS  PubMed  Google Scholar 

  28. Gloor J, Stegall MD. Sensitized renal transplant recipients: current protocols and future directions. Nat Rev Nephrol. 2010;6:297–306.

    Article  PubMed  Google Scholar 

  29. Lefaucheur C, Suberbielle-Boissel C, Hill GS, et al. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Contrib Nephrol 2009;162:1–12.

    Article  CAS  PubMed  Google Scholar 

  30. Lefaucheur C, Loupy A, Vernerey D, et al. Antibody-mediated vascular rejection of kidney allografts: a population-based study. Lancet. 2013;381:313–9.

    Article  CAS  PubMed  Google Scholar 

  31. Taner T, Gandhi MJ, Sanderson SO, et al. Prevalence, course and impact of HLA donor-specific antibodies in liver transplantation in the first year. Am J Transplant. 2012;12:1504–10.

    Article  CAS  PubMed  Google Scholar 

  32. Ravindra KV, Buell JF, Kaufman CL, et al. Hand transplantation in the United States: experience with 3 patients. Surgery. 2008;144:638–43; discussion 43–4.

    Article  PubMed  Google Scholar 

  33. Schneeberger S, Gorantla VS, Brandacher G, et al. Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg. 2013;257:345–51.

    Article  PubMed Central  PubMed  Google Scholar 

  34. Wu S, Xu H, Chen B, et al. Sensitized recipients exhibit accelerated but not hyperacute rejection of vascularized composite tissue allografts. Transplantation. 2011;92:627–33.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  35. Kaufman CL, Ouseph R, Blair B, et al. Graft vasculopathy in clinical hand transplantation. Am J Transplant. 2012;12:1004–16.

    Article  CAS  PubMed  Google Scholar 

  36. Solez K, Colvin RB, Racusen LC, et al. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (ʻCAN’). Am J Transplant. 2007;7:518–26.

    Article  CAS  PubMed  Google Scholar 

  37. Kanitakis J, McGregor B, Badet L, et al. Absence of c4d deposition in human composite tissue (hands and face) allograft biopsies: an immunoperoxidase study. Transplantation. 2007;84:265–7.

    Article  CAS  PubMed  Google Scholar 

  38. Landin L, Cavadas PC, Ibanez J, Roger I, Vera-Sempere F. CD3 + -mediated rejection and C4d deposition in two composite tissue (bilateral hand) allograft recipients after induction with alemtuzumab. Transplantation. 2009;87:776–81.

    Article  CAS  PubMed  Google Scholar 

  39. Reibke R, Garbi N, Ganss R, Hammerling GJ, Arnold B, Oelert T. CD8 + regulatory T cells generated by neonatal recognition of peripheral self-antigen. Proc Natl Acad Sci U S A. 2006;103:15142–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  40. Zhang ZX, Yang L, Young KJ, DuTemple B, Zhang L. Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nat Med. 2000;6:782–9.

    Article  CAS  PubMed  Google Scholar 

  41. Haribhai D, Lin W, Relland LM, Truong N, Williams CB, Chatila TA. Regulatory T cells dynamically control the primary immune response to foreign antigen. J Immunol. 2007;178:2961–72.

    Article  CAS  PubMed  Google Scholar 

  42. Monteiro M, Almeida CF, Caridade M, et al. Identification of regulatory Foxp3 + invariant NKT cells induced by TGF-beta. J Immunol. 2010;185:2157–63.

    Article  CAS  PubMed  Google Scholar 

  43. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155:1151–64.

    CAS  PubMed  Google Scholar 

  44. Safinia N, Leech J, Hernandez-Fuentes M, Lechler R, Lombardi G. Promoting transplantation tolerance; adoptive regulatory T cell therapy. Clin Exp Immunol. 2013;172:158–68.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  45. Golshayan D, Jiang S, Tsang J, Garin MI, Mottet C, Lechler RI. In vitro-expanded donor alloantigen-specific CD4 + CD25 + regulatory T cells promote experimental transplantation tolerance. Blood. 2007;109:827–35.

    Article  CAS  PubMed  Google Scholar 

  46. Eljaafari A, Badet L, Kanitakis J, et al. Isolation of regulatory T cells in the skin of a human hand-allograft, up to six years posttransplantation. Transplantation. 2006;82:1764–8.

    Article  CAS  PubMed  Google Scholar 

  47. Hewitt CW, Black KS, Dowdy SF, et al. Composite tissue (limb) allografts in rats. III. Development of donor-host lymphoid chimeras in long-term survivors. Transplantation. 1986;41:39–43.

    Article  CAS  PubMed  Google Scholar 

  48. Granger DK, Briedenbach WC, Pidwell DJ, Jones JW, Baxter-Lowe LA, Kaufman CL. Lack of donor hyporesponsiveness and donor chimerism after clinical transplantation of the hand. Transplantation. 2002;74:1624–30.

    Article  PubMed  Google Scholar 

  49. Thaunat O, Badet L, El-Jaafari A, Kanitakis J, Dubernard JM, Morelon E. Composite tissue allograft extends a helping hand to transplant immunologists. Am J Transplant. 2006;6:2238–42.

    Article  CAS  PubMed  Google Scholar 

  50. Leventhal J, Abecassis M, Miller J, et al. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Transl Med. 2012;4:124ra28.

    Article  PubMed Central  PubMed  Google Scholar 

  51. Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. New Eng J Med. 2008;358:353–61.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  52. Scandling JD, Busque S, Dejbakhsh-Jones S, et al. Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants. Am J Transplant. 2012;12:1133–45.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  53. Pascual J, Perez-Saez MJ, Mir M, Crespo M. Chronic renal allograft injury: early detection, accurate diagnosis and management. Transplant Rev. 2012;26:280–90.

    Article  Google Scholar 

  54. Petruzzo P, Lanzetta M, Dubernard JM, et al. The International Registry on Hand and Composite Tissue Transplantation. Transplantation. 2010;90:1590–4.

    Article  PubMed  Google Scholar 

  55. Morelon E, Kanitakis J, Petruzzo P. Immunological issues in clinical composite tissue allotransplantation: where do we stand today? Transplantation. 2012;93:855–9.

    Article  CAS  PubMed  Google Scholar 

  56. Unadkat JV, Schneeberger S, Horibe EH, et al. Composite tissue vasculopathy and degeneration following multiple episodes of acute rejection in reconstructive transplantation. Am J Transplant. 2010;10:251–61.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kadiyala V. Ravindra MBBS .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Ravindra, K. (2015). Unique Immunological Features of Vascularized Composite Allografts. In: Brandacher, G. (eds) The Science of Reconstructive Transplantation. Stem Cell Biology and Regenerative Medicine. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2071-6_7

Download citation

Publish with us

Policies and ethics